Results 261 to 270 of about 3,009,219 (314)
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
Evaluation of Targeted-Release Capsule Formulations for Protection of the Acid-Sensitive Enzyme Pancreatin Under Fasted and Fed Intestinal Conditions In Vitro. [PDF]
Karimian Azari E +5 more
europepmc +1 more source
Diff-MomentFormer: Generative Diffusion-Augmented Transformer for End-to-End Joint Moment Estimation. [PDF]
Qiao C, Liu E, Ren J, He L.
europepmc +1 more source
An upper limb stroke rehabilitation exercise video dataset. [PDF]
Nandana S +3 more
europepmc +1 more source
High-Performance SiPM Detection Module for Ultra-Fast Time-Resolved Measurements. [PDF]
Fratta G +6 more
europepmc +1 more source
Construction and Application of a Tactile Somatosensory Comfort Model for Scrubbing Tasks. [PDF]
Xu P, Zhai C, Xiao Y, Zhang L, Yu H.
europepmc +1 more source
Sustainable Materials: A Conceptual Gap in Definition. [PDF]
Saeb MR.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Management of endocrine conditions at the end of life
British Journal of Hospital Medicine, 2020An important facet to end-of-life care is deprescribing. This can be challenging when reviewing life-sustaining endocrine medications but, unlike for diabetes, there is no national guidance to support patients and clinicians faced with care planning.
Anne, de Bray +3 more
openaire +2 more sources

